Infusion Chemotherapy for Soft Tissue Sarcomas
@inproceedings{Benjamin1983InfusionCF, title={Infusion Chemotherapy for Soft Tissue Sarcomas}, author={R. Benjamin and B. Yap}, year={1983} }
Adriamycin has formed the backbone of sarcoma chemotherapy since its introduction into clinical practice. The pioneering studies in this field by the late Dr. Jeffrey Gottlieb demonstrated modest but definite improvement in response rate, remission duration and survival when Adriamycin was combined with DIC and slight further improvement with the addition of cyclophosphamide [1–5]. Other drugs have been relatively ineffective, and the CyVADIC regimen, introduced in 1973, remains the standard of… Expand
Topics from this paper
13 Citations
The treatment of soft tissue sarcomas with focus on chemotherapy: a review.
- Medicine
- Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology
- 1986
- 25
The Role of Chemotherapy in the Treatment of Adult Soft Tissue Sarcomas
- Medicine, Biology
- Oncology
- 1999
- 48
Response to chemotherapy does not predict survival after resection of sarcomatous pulmonary metastases.
- Medicine
- The Annals of thoracic surgery
- 1991
- 78
Rhabdomyosarcoma of the oral soft tissues.
- Medicine
- Oral surgery, oral medicine, and oral pathology
- 1987
- 41
Systemic treatment of advanced or metastatic soft tissue sarcomas.
- Medicine
- Cancer treatment and research
- 1991
- 15
Freireich's laws in the treatment of sarcomas.
- Biology, Medicine
- Clinical cancer research : an official journal of the American Association for Cancer Research
- 1997
- 2
- PDF
Soft Tissue Sarcomas: New Developments in the Multidisciplinary Approach to Treatment
- Medicine
- Cancer Treatment and Research
- 1991
- 13
- Highly Influenced
References
SHOWING 1-5 OF 5 REFERENCES
Chemotherapy of sarcomas with a combination of adriamycin and dimethyl triazeno imidazole carboxamide
- Medicine
- Cancer
- 1972
- 202
Cyclophosphamide, vincristine, adriamycin, and DTIC (CYVADIC) combination chemotherapy for the treatment of advanced sarcomas.
- Medicine
- Cancer treatment reports
- 1980
- 121
Reduction of doxorubicin cardiotoxicity by prolonged continuous intravenous infusion.
- Medicine
- Annals of internal medicine
- 1982
- 709